Microbial colonization and antibacterial resistance patterns after boston type 1 keratoprosthesis

Ophthalmology

Volumn 120, Issue 8, 2013, Pages 1521-1528

  Robert, Marie Claude ^a   Eid, Elie Patrice ^a   Saint Antoine, Pierre ^a   Harissi Dagher, Mona ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BOSTON TYPE 1 KERATOPROSTHESIS; CASE CONTROL STUDY; CONTROLLED STUDY; CORYNEBACTERIUM; CROSS-SECTIONAL STUDY; FEMALE; FUNGAL COLONIZATION; HUMAN; KERATOPROSTHESIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PENETRATING KERATOPLASTY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS INFECTION; RISK ASSESSMENT; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; ARTIFICIAL ORGANS; BACTERIA; CASE-CONTROL STUDIES; CONJUNCTIVA; CORNEA; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGI; HUMANS; KERATOPLASTY, PENETRATING; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS; QUESTIONNAIRES; RISK FACTORS;

EID: 84881180636     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.01.003     Document Type: Article

References (39)

1. J.J. Ma, J.M. Graney, and C.H. Dohlman Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure Int Ophthalmol Clin 45 2005 49 59
2. F. Yaghouti, M. Nouri, and J.C. Abad Keratoprosthesis: preoperative prognostic categories Cornea 20 2001 19 23
3. A.J. Aldave, K.M. Kamal, R.C. Vo, and F. Yu The Boston type 1 keratoprosthesis: improving outcomes and expanding indications Ophthalmology 116 2009 640 651
4. J.C. Bradley, E.G. Hernandez, I.R. Schwab, and M.J. Mannis Boston type 1 keratoprosthesis: the University of California Davis experience Cornea 28 2009 321 327
5. H.F. Chew, B.D. Ayres, and K.M. Hammersmith Boston keratoprosthesis outcomes and complications Cornea 28 2009 989 996
6. B.L. Zerbe, M.W. Belin, J.B. Ciolino Boston type 1 Keratoprosthesis Study Group Results from the multicenter Boston type 1 keratoprosthesis study Ophthalmology 113 2006 1779 1784
7. K. Dunlap, G. Chak, and J.V. Aquavella Short-term visual outcomes of Boston type 1 keratoprosthesis implantation Ophthalmology 117 2010 687 692
8. M.C. Robert, and M. Harissi-Dagher Boston type 1 keratoprosthesis: the CHUM experience Can J Ophthalmol 46 2011 164 168
9. A. Aldave, V. Sangwan, and S. Basu International results with the Boston type I keratoprosthesis Ophthalmology 119 2012 1530 1538
10. A.P. Patel, E.I. Wu, D.C. Ritterband, and J.A. Seedor Boston type 1 keratoprosthesis: the New York Eye and Ear experience Eye (Lond) 26 2012 418 425
11. M.A. Greiner, J.Y. Li, and M.J. Mannis Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis Ophthalmology 118 2011 1543 1550
12. A.F. Elsahn, E.H. Yildiz, and D.L. Jungkind In vitro susceptibility patterns of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus corneal isolates to antibiotics Cornea 29 2010 1131 1135
13. M. McDonald, and J. Blondeau Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones J Cataract Refract Surg 36 2010 1588 1598
14. R.E. Fintelmann, J.I. Maguire, and A.C. Ho Characteristics of endophthalmitis in patients with the Boston keratoprosthesis Cornea 28 2009 877 878
15. M. Nouri, H. Terada, and E.C. Alfonso Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors Arch Ophthalmol 119 2001 484 489
16. C.H. Dohlman, M. Harissi-Dagher, and B.F. Khan Introduction to the use of the Boston keratoprosthesis Expert Rev Ophthalmol 1 2006 41 48
17. B.L. Svarstad, B.A. Chewning, B.L. Sleath, and C. Claesson The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence Patient Educ Couns 37 1999 113 124
18. K. Sejpal, F. Yu, and A. Aldave The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency Cornea 30 2011 1187 1194
19. C.C. Chan, and E.J. Holland Infectious keratitis after Boston type 1 keratoprosthesis implantation Cornea 31 2012 1128 1134
20. J.P. Garcia Jr., D.C. Ritterband, D.F. Buxton, and J. De la Cruz Evaluation of the stability of Boston type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography Cornea 29 2010 1031 1035
21. Antimicrobial prophylaxis for life: as important as ever Boston KPro news Fall 1 2011 3. Available at: http://www.masseyeandear.org/gedownload!/ 2011%20KPro%20newsletter.pdf?item-id=70213024 Accessed December 10, 2012
22. M. Harissi-Dagher, and C. Dohlman The Boston Keratoprosthesis Contemp Ophthalmol 5 2006 1 7
23. R.S. Ramchandran, D.A. Diloreto Jr., and M.M. Chung Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis Ophthalmology 119 2012 674 681
24. M. Durand, and C. Dohlman Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis Cornea 28 2009 896 901
25. S.D. Barnes, C.H. Dohlman, and M.L. Durand Fungal colonization and infection in Boston keratoprosthesis Cornea 26 2007 9 15
26. C.C. Chan, and E.J. Holland Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation Cornea 31 2012 346 349
27. H.J. Ingraham, and E.D. Donnenfeld Anesthesia for corneal surgery S. Greenbaum, Ocular Anesthesia 1997 Saunders Philadelphia 105
28. H. Oguz, E. Oguz, S. Karadede, and G. Asian The antibacterial effect of topical anesthetic proparacaine on conjunctival flora Int Ophthalmol 23 1999 117 120
29. S.H. Park, J.A. Lim, and J.S. Choi The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics Cornea 28 2009 68 72
30. J.M. Blondeau Fluoroquinolones: mechanism of action, classification, and development of resistance Surv Ophthalmol 49 suppl 2004 S73 S78
31. R.E. Fintelmann, E.N. Hoskins, and T.M. Lietman Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures Arch Ophthalmol 129 2011 399 402
32. E. Milder, J. Vander, C. Shah, and S. Garg Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection Ophthalmology 119 2012 1420 1424
33. S.B. Dave, H.S. Toma, and S.J. Kim Ophthalmic antibiotic use and multidrug-resistant Staphylococcus epidermidis: a controlled, longitudinal study Ophthalmology 118 2011 2035 2040
34. J. Segreti, R.N. Jones, and J.S. Bertino Jr. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones J Ocul Pharmacol Ther 28 2012 3 11
35. B.D. Gaynor, J.D. Chidambaram, and V. Cevallos Topical ocular antibiotics induce bacterial resistance at extraocular sites Br J Ophthalmol 89 2005 1097 1099
36. S.J. Kim, and H.S. Toma Ophthalmic antibiotics and antimicrobial resistance: a randomized, controlled study of patients undergoing intravitreal injections Ophthalmology 118 2011 1358 1363
37. F. Magalhães, H. Nascimento, and D. Ecker Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine Cornea 2012 Feb 7 [Epub ahead of print]
38. J.F. Yu, L. Liang, and Y.F. Huang Keratoprosthesis surveillance cultures [letter] Ophthalmology 119 2012 202 203
39. K.W. Ward, J.F. Lepage, and J.Y. Driot Nonclinical pharmacodynamics, pharmacokinetics, and safety of BOL-303224-A, a novel fluoroquinolone antimicrobial agent for topical ophthalmic use J Ocul Pharmacol Ther 23 2007 243 256